A Randomized, Double Blind, Placebo Controlled, Clinical Study to Examine the Benefits of an Oral Product in Panelists With Menopausal Symptoms Including Vasomotor Symptoms (VMS).
This record was last updated July 16, 2025 (before its estimated July 25, 2025 completion). Its status may not reflect the trial's current state.
Summary
Randomized, Double-Blind, Placebo-Controlled, Single-Center Clinical Study with a Run-in Baseline, Daily Diary Log, and Validated Questionnaires (Greene GCS) with Oral Dietary Supplement
Protocol Amendment History
1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-13.
Status change: Not Yet Recruiting → Recruiting2025-07-11